Lv22
120 积分 2024-09-02 加入
Extended Analyses of Pelacarsen and Cardiovascular Outcomes in Patients with High Lipoprotein(a)
20小时前
求助中
Effect of Targeting ApoC-III With Plozasiran on Lipoprotein Particle Size and Number in Hypertriglyceridemia
6个月前
已完结
Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial
8个月前
已完结
皖公网安备34019202002308
